Levothyroxine Sodium 25 mcg Tablets
Major Pharmaceuticals is recalling Levothyroxine Sodium 25 mcg tablets due to subpotency.
Contact your healthcare provider or pharmacist if you have concerns about your medication. Do not stop taking your medication without consulting a medical professional.
Why it was recalled
Major Pharmaceuticals is recalling Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg) due to the product being subpotent. The affected product is packaged in 100-count cartons containing 10 x 10 unit dose blisters.
Is mine affected?
This recall covers 12 products. Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Levothyroxine Sodium Tablets, USP
| Strength | NDC / UPC |
|---|---|
| 112 mcg | NDC 0904-6954-61 |
| 75 mcg | NDC 0904-6951-61 |
| 88 mcg | NDC 0904-6952-61 |
| 50 mcg | – |
| 50 mcg | NDC 0904-6950-61 |
| 125 mcg | NDC 0904-6955-61 |
| 150 mcg | – |
| 150 mcg | NDC 0904-6956-61 |
+4 more affected products. See the full list at the official source below.
Official source
Editorial summary by Recall Canary · last updated 2026-07-20 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification